Aprepitant Injection Placebo

DRUG2 trials

Sponsors

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd., Qilu Pharmaceutical (Hainan) Co., Ltd.

Conditions

Post-operative Nausea and Vomiting (PONV)Postoperative Nausea and Vomiting

Phase 3

Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting

Not yet recruitingNCT06543966

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.Post-operative Nausea and Vomiting (PONV)

Start: 2024-10-28End: 2026-03-28Target: 486Updated: 2024-08-09

Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting

CompletedNCT06932107

Qilu Pharmaceutical (Hainan) Co., Ltd.Postoperative Nausea and Vomiting

Start: 2024-02-02End: 2024-06-05Updated: 2025-04-23